BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 32135457)

  • 1. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
    Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxyshikonin isolated from
    Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
    Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
    [No Abstract]   [Full Text] [Related]  

  • 3. Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells.
    Yao W; Lin Z; Shi P; Chen B; Wang G; Huang J; Sui Y; Liu Q; Li S; Lin X; Liu Q; Yao H
    Biochem Pharmacol; 2020 Jan; 171():113680. PubMed ID: 31669234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism.
    Chen GQ; Tang CF; Shi XK; Lin CY; Fatima S; Pan XH; Yang DJ; Zhang G; Lu AP; Lin SH; Bian ZX
    Oncotarget; 2015 Sep; 6(27):24148-62. PubMed ID: 26160839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells.
    Wang J; Wang J; Li L; Feng L; Wang YR; Wang Z; Tan NH
    J Ethnopharmacol; 2021 Feb; 266():113438. PubMed ID: 33017635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
    Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
    Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
    Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X
    Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isobavachalcone isolated from
    Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
    Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
    [No Abstract]   [Full Text] [Related]  

  • 9. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
    He W; Lai R; Lin Q; Huang Y; Wang L
    J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a fluorescent small-molecule enhancer for therapeutic autophagy in colorectal cancer by targeting mitochondrial protein translocase TIM44.
    Huang Y; Zhou J; Luo S; Wang Y; He J; Luo P; Chen Z; Liu T; Tan X; Ou J; Miao H; Liang H; Shi C
    Gut; 2018 Feb; 67(2):307-319. PubMed ID: 27849558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
    Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
    BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
    Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
    Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer.
    Wang B; Zhou TY; Nie CH; Wan DL; Zheng SS
    Biochem Biophys Res Commun; 2018 May; 499(2):156-163. PubMed ID: 29548826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression.
    Weng ML; Chen WK; Chen XY; Lu H; Sun ZR; Yu Q; Sun PF; Xu YJ; Zhu MM; Jiang N; Zhang J; Zhang JP; Song YL; Ma D; Zhang XP; Miao CH
    Nat Commun; 2020 Apr; 11(1):1869. PubMed ID: 32313017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway.
    Ghanaatgar-Kasbi S; Amerizadeh F; Rahmani F; Hassanian SM; Khazaei M; Ferns GA; Avan A
    IUBMB Life; 2019 Dec; 71(12):1929-1936. PubMed ID: 31359579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway.
    Li F; Wan X; Li Z; Zhou L
    Cancer Med; 2024 Jun; 13(11):e7382. PubMed ID: 38872380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
    Li Q; Tang H; Hu F; Qin C
    J Cell Biochem; 2019 Mar; 120(3):3853-3860. PubMed ID: 30321450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer.
    Zhu SL; Qi M; Chen MT; Lin JP; Huang HF; Deng LJ; Zhou XW
    Phytomedicine; 2024 Jun; 128():155377. PubMed ID: 38503154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.
    Martinelli E; Troiani T; D'Aiuto E; Morgillo F; Vitagliano D; Capasso A; Costantino S; Ciuffreda LP; Merolla F; Vecchione L; De Vriendt V; Tejpar S; Nappi A; Sforza V; Martini G; Berrino L; De Palma R; Ciardiello F
    Int J Cancer; 2013 Nov; 133(9):2089-101. PubMed ID: 23629727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.